Press release
Inhaler Corticosteroid Device Market Research Reveals Strong 6.6% CAGR Outlook Through 2030
Inhaler Corticosteroid Device Market
Projected Growth and Market Size of the Inhaler Corticosteroid Device Market
The inhaler corticosteroid device market is anticipated to expand significantly, reaching a value of $23.18 billion by 2030. This growth is expected to occur at a compound annual growth rate (CAGR) of 6.6%. Several factors are fueling this upward trajectory, including the integration of artificial intelligence (AI) and the Internet of Things (IoT) into inhaler devices, the development of environmentally friendly inhalers, growth in telehealth services, personalized medicine delivery systems, and increasing demand from emerging markets. Key trends expected to influence the market during the forecast period include smart inhaler technology, tailored dosage management, telehealth-enabled monitoring, sustainable device designs, and improvements in aerosol delivery methods.
Download a free sample of the inhaler corticosteroid device market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25794&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Leading Market Players Steering the Inhaler Corticosteroid Device Industry
The market is dominated by a number of well-established pharmaceutical and device companies, including AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Teijin Pharma Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Mundipharma International Limited, Lupin Limited, Zydus Lifesciences Limited, Recipharm AB, Glenmark Pharmaceuticals Limited, Orion Corporation, Beximco Pharmaceuticals Limited, and PARI Medical Holding GmbH.
Expanding Inhaled Drug Delivery Capabilities Through Strategic Acquisition
In May 2023, Phillips-Medisize Corporation, a U.S.-based firm specializing in medical technology and drug delivery, and a subsidiary of Molex LLC, acquired Vectura Group Ltd., a UK-based company focused on inhalation formulation and device development, including dry-powder inhalers. Although the financial details were not disclosed, this acquisition aims to broaden Phillips-Medisize's inhaled drug delivery portfolio, enhance their capabilities in inhalation device design, and accelerate innovation in combination products for pharmaceutical and biotech clients.
View the full inhaler corticosteroid device market report:
https://www.thebusinessresearchcompany.com/report/inhaler-corticosteroid-device-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Innovative Treatment Approaches Emerging in the Inhaler Corticosteroid Device Market
The market is witnessing the introduction of novel inhaler solutions designed to improve treatment outcomes. A notable innovation is the development of rescue inhalers that combine albuterol and budesonide, providing both rapid airway relief and inflammation reduction in a single device. For example, in January 2024, AstraZeneca PLC launched AIRSUPRA, the first FDA-approved rescue inhaler combining these two medications specifically for adults with asthma. This product is intended for as-needed use, offering immediate relief from bronchoconstriction while simultaneously addressing airway inflammation, thereby reducing the risk of severe asthma attacks. This dual-action inhaler represents a new treatment paradigm backed by clinical trials demonstrating its superiority over albuterol-only inhalers.
Key Segments Defining the Global Inhaler Corticosteroid Device Market
The inhaler corticosteroid device market is segmented by various parameters to better understand its scope:
1) Product Type: Metered-Dose Inhalers, Dry Powder Inhalers, and Soft Mist Inhalers.
2) Formulation Type: Fluticasone Propionate, Budesonide, Beclomethasone, and Mometasone Furoate.
3) Distribution Channel: Online Pharmacies, Retail Pharmacies, Direct Sales, and Hospital Pharmacies.
4) Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Other Applications.
5) End-User: Hospitals, Homecare, Specialty Clinics, and Other End-Users.
Detailed Subcategories Within Product Types
Further subdivisions include:
- Metered-Dose Inhalers: Conventional, Breath-Actuated, and Spacer-Integrated variants.
- Dry Powder Inhalers: Single-Dose, Multi-Dose, and Reservoir types.
- Soft Mist Inhalers: Manual and Battery-Operated versions.
These segments help provide a clear picture of the diverse range of products and services encompassed within the inhaler corticosteroid device market.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inhaler Corticosteroid Device Market Research Reveals Strong 6.6% CAGR Outlook Through 2030 here
News-ID: 4571433 • Views: …
More Releases from The Business Research Company
Intraocular Lens Market Study Explores Industry Growth Toward $9.49 Billion
The intraocular lens market is on the brink of significant growth as advancements in vision correction technologies continue to evolve. With increasing demand for better visual outcomes and a shift toward premium products, this market is set to expand rapidly over the next several years. Let's explore the market's size, key players, emerging trends, and segmentation to gain a comprehensive understanding.
Intraocular Lens Market Size Projections Through 2030
The intraocular…
Intramedullary Nailing System Market Research Reveals Path To $1.87 Billion By 2 …
The intramedullary nailing system market is poised for significant expansion over the coming years as advances in orthopedic technology and rising healthcare needs drive demand. With a growing aging population and an increasing focus on personalized and minimally invasive treatments, this sector is set to experience remarkable growth by the end of the decade. Let's explore the market size projections, key players, emerging trends, and segment details that shape this…
Intracranial Stents Market Demonstrates Long-Term Growth Potential At 15.6% CAGR
The intracranial stents market is positioned for significant expansion over the coming years, driven by advances in neurovascular treatment options and growing clinical demand. As medical technology evolves, the sector is set to experience considerable growth, fueled by innovations and increasing focus on stroke and aneurysm care. Let us explore the market size projections, the main players, emerging trends, and the key segments shaping this industry.
Rapid Growth Trajectory of the…
Interventional Tumor Ablation Market Outlook Signals Expansion To $2.66 Billion …
The interventional tumor ablation market is positioned for significant growth in the coming years, driven by technological advancements and evolving cancer treatment approaches. This sector is witnessing an increased focus on precision therapies and minimally invasive techniques, which are reshaping how tumors are treated worldwide. Let's explore the market's size projections, key players, emerging trends, and the main segments that define this industry.
Projected Growth and Market Size of the Interventional…
More Releases for Inhaler
Z!NGHA Introduces Dual-Chamber Aromatherapy Nasal Inhaler
Image: https://www.getnews.info/uploads/e696f4bdf98524eaf4f4f4bc89f2369f.jpg
Miami, FL - December 09, 2024 - Z!NGHA, a new player in the wellness space, is thrilled to announce the launch of its flagship product, the Z!NGHA Double Nasal Inhaler, an innovation that combines the therapeutic benefits of aromatherapy and essential oils with the on-the-go convenience of a dual-chamber nasal inhaler. Unlike the industry standard single chamber nasal inahlers, Z!ngha offers simultaneous inhalation through both nostrils, redefining aromatherapy for…
Asthma Inhaler Device Market By Type (Metered-dose inhaler, MDI with a spacer, D …
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. The research report on the market for asthma inhaler devices offers analysis and insights into the numerous aspects that are anticipated to be present over the course of the forecast period as well as…
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma…
Oxygen Inhaler Market Size, Share, Growth & Forecast 2026
Global Oxygen Inhaler Market report focuses on Oxygen Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents the overall Oxygen Inhaler market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for…
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the…
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…
